MC
BSX icon

Maverick Capital’s Boston Scientific BSX Stock Holding History

Maverick Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$62.8M Buy
+1,000,000
New +$80M 0.72% 41

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Maverick Capital's BSX Position: Q1 2026 in Review

Maverick Capital increased its Boston Scientific (BSX) stake by 42% in Q1 2026, buying an estimated $100M and bringing the position to 4,195,089 shares worth $263M. The position accounts for 3.04% of the portfolio, ranked #9.

Maverick Capital first reported a position in BSX in Q1 2018 and has held it in 11 quarters since. The position peaked at $281M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Maverick Capital held 4,195,089 shares of Boston Scientific worth $263M as of Q1 2026.
  • Maverick Capital bought 1,250,835 Boston Scientific shares in Q1 2026, an estimated $100M.
  • Boston Scientific made up 3.04% of Maverick Capital's portfolio in Q1 2026, its #9 holding.
  • Maverick Capital first reported a position in Boston Scientific in Q1 2018 and has held it in 11 quarters since.
  • Maverick Capital's Boston Scientific position peaked at $281M in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Maverick Capital's 13F filing for Q1 2026, filed 15 May 2026.